SEARCH

SEARCH BY CITATION

References

  • 1
    O’Brien TF, Stelling J. Integrated multilevel surveillance of the world’s infecting microbes and their resistance to antimicrobial agents. Clin Microbiol Rev 2011; 24: 281295.
  • 2
    Jones RN, Masterton R. Determining the value of antimicrobial surveillance programs. Diagn Microbiol Infect Dis 2001; 41: 171175.
  • 3
    Kahlmeter G, Brown DF, Goldstein FW et al. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 2003; 52: 145148.
  • 4
    Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI.
  • 5
    Kahlmeter G. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints. Clin Microbiol Infect 2008; 14 (Suppl 1): 169174.
  • 6
    Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI.
  • 7
    Leclercq R, Canton R, Giske C et al. Expert rules in antimicrobial susceptibility testing. Version 1. Availble at: http://www.eucast.org. (last accessed 2 July 2012).
  • 8
    Leclercq R, Canton R, Brown DF et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2011; Oct 2012. doi: 10.1111/j.1469-0691.2011.03703.x [Epub ahead of print].
  • 9
    European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST breakpoint table version 1.0. Availble at: http://www.eucast.org. (last accessed 2 July 2012).
  • 10
    Hombach M, Bloemberg GV, Bottger EC. Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli. J Antimicrob Chemother 2012; 67: 622632.
  • 11
    European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST breakpoint table version 1.1. Available at: http://www.eucast.org. (last accessed 2 July 2012).
  • 12
    Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 2007; 44: 867873.
  • 13
    Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; Twenty-first informational supplement; M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute.
  • 14
    Gagliotti C, Balode A, Baquero F et al. Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill 2011; 16: [Epub ahead of print].
  • 15
    Jones RN. Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997–2001). Semin Respir Crit Care Med 2003; 24: 121134.
  • 16
    Rhomberg PR, Jones RN. Summary trends for the Meropenem yearly susceptibility test information collection program: a 10-year experience in the United States (1999–2008). Diagn Microbiol Infect Dis 2009; 65: 414426.